Target ID:dt1214
CID:118115473
Compound Name:Ritlecitinib
Gene ID:3718
Gene Name:JAK3
Species:Homo sapiens (human)
PubMed IDs:--
Action:Inhibition

Knowledge Graph

Target IDCIDCompound NameGene IDGene NameSpeciesAction
dt1070 44603362 Solcitinib 3718 JAK3 Homo sapiens (human) Inhibition Details
dt1095 49831257 Filgotinib 3718 JAK3 Homo sapiens (human) Inhibition Details
dt1163 57928403 Peficitinib 3718 JAK3 Homo sapiens (human) Inhibitor Details
dt1165 57928403 Peficitinib 3718 JAK3 Homo sapiens (human) -- Details
dt1166 57928403 Peficitinib 3718 JAK3 Homo sapiens (human) Inhibition Details
dt1172 58557659 Upadacitinib 3718 JAK3 Homo sapiens (human) -- Details
dt1173 58557659 Upadacitinib 3718 JAK3 Homo sapiens (human) Inhibitor Details
dt1176 58557659 Upadacitinib 3718 JAK3 Homo sapiens (human) Inhibition Details
dt1212 118115473 Ritlecitinib 3718 JAK3 Homo sapiens (human) -- Details
dt1213 118115473 Ritlecitinib 3718 JAK3 Homo sapiens (human) Tyrosine-protein kinase JAK3 inhibitor Details

Drug IDDrug NameTypeDrugBank IDTargetsCategoryLatest Progress
Drug159 Ritlecitinib Chemical drug -- -- -- Under clinical trials Details

Compound IDSource IDSource TypeCompound NameMolecular WeightMolecular FormulaMolecular Species
No data available

Disease IDDisease NameDefinitionMechanism
No data available

Strategy IDTherapy StrategySynonymsRelated DrugsMechanism
No data available